SITAGLIPTIN MYLAN 100 MG TBL FLM 28
Rychlý přehled
| Dosage form | Tablets film-coated |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, podmínky úhrady (vykazovací limit) ale nebyl stanoven. Maximální doplatek: 635,68 Kč. Maximální cena: 878,43 Kč. |
| Kdo může předepsat | Prescription is not conditional on a medical specialization. |
| Složení | Monohydrát sitagliptin-hydrochloridu (113,374 mg), sitagliptin (100 mg), mikrokrystalická celulosa, sodná sůl kroskarmelosy, koloidní bezvodý oxid křemičitý, dihydrát hydrogenfosforečnanu vápenatého, magnesium-stearát,… |
| Dostupnost / výpadek | Ukončeno The latest report from the manufacturer is from 29. 1. 2026. Výroba byla ukončena s platností od 3. 2. 2026. The manufacturer lists medicines with the following code as a potential substitute: 0280448 |
| Kód SÚKL | 0265174 |
What is the maximum co-payment for SITAGLIPTIN MYLAN?
If the insurance company contributes, the maximum co-payment is 635,68 Kč. The maximum pharmacy price is 878,43 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
Yes, but the reimbursement conditions (reporting limit) have not been set.
Does SITAGLIPTIN MYLAN have a counted co-payment set?
No, this medicine has no counted co-payment.
How much does the insurance company pay for one dispensed reimbursed pack?
242,75 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe SITAGLIPTIN MYLAN?
Prescription is not conditional on a medical specialization.
What is the composition of SITAGLIPTIN MYLAN?
Monohydrát sitagliptin-hydrochloridu (113,374 mg), sitagliptin (100 mg), mikrokrystalická celulosa, sodná sůl kroskarmelosy, koloidní bezvodý oxid křemičitý, dihydrát hydrogenfosforečnanu vápenatého, magnesium-stearát, polyvinylalkohol, makrogol 3350, ointmentek, oxid titaničitý, červený oxid železitý, žlutý oxid železitý. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
- Documents could not be found
Which medicines are similar to SITAGLIPTIN MYLAN?
The medicine belongs to ATC group A10BH01 – . Medicines with the same active substance can be found here.
Who manufactures SITAGLIPTIN MYLAN?
Informace o výrobci není dostupná.
Is the medicine in shortage?
The latest report from the manufacturer is from 29. 1. 2026. Production was terminated with effect from 3. 2. 2026. The manufacturer lists medicines with the following code as a potential substitute:
What is the unique code for SITAGLIPTIN MYLAN?
The medicine has code 0265174. Code details can be found here.
How many packs of SITAGLIPTIN MYLAN were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of SITAGLIPTIN MYLAN were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 17. 07. 2026